Ginkgo Bioworks Holdings (DNA) Cash from Discontinued Operations (2025 - 2026)
Ginkgo Bioworks Holdings' (DNA) quarterly Cash from Discontinued Operations came in at -$2.1 million in Q2 2026, down 23.67% on a YoY basis from -$2.8 million in Q2 2025, and down 730.04% quarter-over-quarter from -$253000.0 in Q1 2026.
Powered by 
Analysis
Ginkgo Bioworks Holdings (DNA) Cash from Discontinued Operations (2025 - 2026) Analysis & Trends
Ginkgo Bioworks Holdings (DNA) has reported Cash from Discontinued Operations for 2 consecutive years, with -$2.1 million the latest figure, recorded in Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | - |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | - |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | - |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | - |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -2.10 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -2.90 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.10 Mn |
| Mar 31, 2026 | -253,000.00 |
| Jun 30, 2025 | -1.70 Mn |
| Mar 31, 2025 | -8.77 Mn |